Andrés Sebastián Cadena Paredes

Mr. Andrés Sebastián Cadena Paredes

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
PGPatricia Guevara
Patricia Guevara
EPElius Paz-Cruz
Elius Paz-Cruz
VPViviana Alejandra Ruiz Pozo
Viviana Alejandra Ruiz Pozo
SCSantiago Cadena-Ullauri
Santiago Cadena-Ullauri
RTRafael Tamayo-Trujillo
Rafael Tamayo-Trujillo
AZAna Karina Zambrano
Ana Karina Zambrano
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by epithelial barrier dysfunction, immune dysregulation, and marked clinical heterogeneity. Although sex hormones and gut microbiota have independently been implicated in AD, their potential interactions remain incompletely understood. This narrative review integrates evidence from clinical, experimental, and preclinical studies examining the interplay among progesterone, testosterone, gut microbiota, and AD, with emphasis on immune regulation, epithelial barrier function, and gut–skin communication. Overall, the available evidence suggests that progesterone is predominantly associated with type 2 immune responses, alterations in epithelial barrier homeostasis, and context-dependent microbial remodeling. In contrast, physiological testosterone is generally associated with immunoregulatory effects and microbial profiles enriched in short-chain fatty acid-producing bacteria, whereas local androgen metabolism may contribute to skin barrier dysfunction. Current evidence also supports a bidirectional relationship between gut microbiota and sex hormones, whereby hormonal fluctuations influence microbial composition while microbial metabolism may modify steroid hormone bioavailability. Collectively, these findings support an integrated endocrine–microbial–immune framework that may contribute to AD beyond cutaneous inflammation. Although direct evidence simultaneously evaluating these components remains limited, this framework may help explain sex-specific differences in disease susceptibility, severity, and clinical course while guiding future mechanistic studies of the hormone–gut microbiota–skin axis.

1 December 2020 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
VCViviana Chiluisa-Utreras
Viviana Chiluisa-Utreras
KJKatherine Alejandra Medrano Jara
Katherine Alejandra Medrano Jara
APAndrés Sebastián Cadena Paredes
Andrés Sebastián Cadena Paredes
Ramiro AcurioRamiro Acurio
Ramiro Acurio

11 November 2026 in Medwave
Verified
Journal Article
Closed access
RTRafael Tamayo-Trujillo
Rafael Tamayo-Trujillo
VPViviana Alejandra Ruiz Pozo
Viviana Alejandra Ruiz Pozo
LHLenín Guamán Herrera
Lenín Guamán Herrera
EJEmily Jaramillo Jácome
Emily Jaramillo Jácome
APAndrés Sebastián Cadena Paredes
Andrés Sebastián Cadena Paredes
AZAna Karina Zambrano
Ana Karina Zambrano
Introduction Substance abuse is a public health problem resulting from the interaction between exposure, neuroadaptations, and genetic susceptibility. This review aimed to synthesize recent evidence on the genes and neurobiological systems involved in the development of substance abuse. Methods A literature review was conducted, primarily of articles published within the last 10 years. MEDLINE/PubMed, Scopus, Web of Science, ScienceDirect, and specialized genetic and biomedical information resources were consulted, yielding 158 references on the genetics of addiction, neurotransmission, neuroplasticity, and the use of alcohol, nicotine, cannabis, cocaine, and opioids were included. Results Addiction arises from the interaction between repeated exposure to substances of abuse, persistent neuroadaptations, and genetic susceptibility. The main neurobiological alterations involve the ventral tegmental area, nucleus accumbens, prefrontal cortex, amygdala, and hippocampus, with participation from the dopaminergic, glutamatergic, GABAergic, opioid, endocannabinoid, cholinergic, serotonergic, and noradrenergic systems. Genetic variants in and have been associated with susceptibility to developing substance use disorders. Furthermore, chronic exposure alters pathways such as cAMP/PKA, CREB, FosB, AP-1, and ERK, which promotes tolerance, dependence, sensitization, and relapse. However, most of the described variants contribute only to a limited extent to susceptibility to substance abuse, and their magnitude may differ depending on the substance, methodological differences between studies, and the type of population studied. Conclusions Susceptibility to addiction may arise from a complex interaction between genetic, neurobiological, and potentially environmental factors. However, larger functional, population-based, and multi-ethnic studies are needed to validate these associations and determine their usefulness in prevention, risk stratification, and personalized therapies.